Impact BioMedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.01	2	0	0	0.05	0.07
Cash & Short-Term Investments	0.01	2	0	0	0.05	0.07
Cash Growth	-99.55%	199800.00%	-50.00%	-95.65%	-36.42%	-33.46%
Other Receivables	-	-	0.13	-	-	-
Receivables	0.21	0.18	0.33	0.02	0.2	-
Prepaid Expenses	0.21	0.27	-	0.06	0	-
Other Current Assets	-	-	-	0.04	0.04	0.04
Total Current Assets	0.92	2.45	0.33	0.12	0.29	0.11
Property, Plant & Equipment	0.01	0.02	0.29	0.28	-	-
Long-Term Investments	-	-	-	0.78	4.82	0.63
Goodwill	-	-	25.09	25.09	25.09	25.09
Other Intangible Assets	17.28	17.81	18.92	20.03	21.15	22.26
Total Assets	18.21	20.29	44.63	46.5	56.43	48.09
Accounts Payable	0.58	0.71	0.83	0.54	0.12	0.01
Accrued Expenses	0.34	0.19	0.23	0.06	0.01	0
Short-Term Debt	-	8.84	12.07	9.99	12.52	1.06
Current Portion of Long-Term Debt	22.88	0.04	-	-	-	-
Total Current Liabilities	23.79	9.79	13.14	10.59	12.65	1.07
Long-Term Deferred Tax Liabilities	3.27	3.27	3.24	3.24	3.86	5.25
Total Liabilities	27.06	13.05	16.37	13.83	16.5	6.32
Common Stock	0.01	0.01	0.01	0.07	0.13	0.13
Additional Paid-In Capital	42.87	41.86	38.11	38.11	38.06	38.06
Retained Earnings	-54.75	-37.67	-12.96	-8.63	-1.57	-0.27
Total Common Equity	-11.87	4.2	25.16	29.56	36.61	37.91
Minority Interest	2.96	2.98	3.04	3.11	3.32	3.86
Shareholders' Equity	-8.85	7.24	28.26	32.67	39.92	41.77
Total Liabilities & Equity	18.21	20.29	44.63	46.5	56.43	48.09
Total Debt	22.88	8.88	12.07	9.99	12.52	1.06
Net Cash (Debt)	-22.87	-6.88	-12.07	-9.99	-12.48	-0.99
Net Cash Per Share	-1.91	-0.64	-0.20	-0.14	-0.18	-0.01
Filing Date Shares Outstanding	104.62	12.09	10	70.5	70.5	70.5
Total Common Shares Outstanding	12.19	11.5	10	70.5	70.5	70.5
Working Capital	-22.88	-7.34	-12.8	-10.47	-12.36	-0.96
Book Value Per Share	-0.97	0.37	2.52	0.42	0.52	0.54
Tangible Book Value	-29.15	-13.61	-18.85	-15.57	-9.63	-9.44
Tangible Book Value Per Share	-2.39	-1.18	-1.89	-0.22	-0.14	-0.13
Machinery	0.03	0.03	-	0.03	-	-
Construction In Progress	-	-	-	0.25	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q